The pharmacology of the excitatory neuromuscular junction in the crayfish.
D000409:Alanine / Q000031:analogs & derivatives / Q000494:pharmacology; D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D003400:Astacoidea; D003208:Concanavalin A / Q000494:pharmacology; D004110:Diltiazem / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects; D005971:Glutamates / Q000378:metabolism / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007608:Kainic Acid / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology*; D010069:Oxadiazoles / Q000494:pharmacology; D016318:Quisqualic Acid; D012265:Ribonucleotides / Q000494:pharmacology; D013329:Structure-Activity Relationship; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000470:Alkaloids; D005971:Glutamates; D006634:Histamine H1 Antagonists; D009466:Neuromuscular Blocking Agents; D010069:Oxadiazoles; D012265:Ribonucleotides; D003208:Concanavalin A; D005680:gamma-Aminobutyric Acid; D016318:Quisqualic Acid; D004110:Diltiazem; D000409:Alanine; D007608:Kainic Acid